Shan Zhao1, Nanjing Hao1, John X J Zhang1, P Jack Hoopes1,2, Fridon Shubitidze1, Zi Chen3,4. 1. Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, 03755, NH, USA. 2. Geisel School of Medicine, Dartmouth College, 1 Rope Ferry Road, Hanover, 03755, NH, USA. 3. Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, 03755, NH, USA. zchen33@bwh.harvard.edu. 4. Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115, MA, USA. zchen33@bwh.harvard.edu.
Abstract
BACKGROUND: Hyperthermia is one of the promising cancer treatment strategies enabled by local heating with the use of tumor-targeting magnetic nanoparticles (MNP) under a non-invasive magnetic field. However, one of the remaining challenges is how to achieve therapeutic levels of heat (without causing damages to regular tissues) in tumors that cannot be effectively treated with anti-tumor drug delivery. RESULTS: In this work, we report a facile method to fabricate magnetic nanorods for hyperthermia by one-step wet chemistry synthesis using 3-Aminopropyltrimethoxysilane (APTMS) as the shape-controlling agent and ferric and ferrous ions as precursors. By adjusting the concentration of APTMS, hydrothermal reaction time, ratios of ferric to ferrous ions, magnetic nanorods with aspect ratios ranging from 4.4 to 7.6 have been produced. At the clinically recommended field strength of 300 Oe (or less) and the frequency of 184 kHz, the specific absorption rate (SAR) of these nanorods is approximately 50 % higher than that of commercial Bionized NanoFerrite particles. CONCLUSIONS: This increase in SAR, especially at low field strengths, is crucial for treating deep tumors, such as pancreatic and rectal cancers, by avoiding the generation of harmful eddy current heating in normal tissues.
BACKGROUND:Hyperthermia is one of the promising cancer treatment strategies enabled by local heating with the use of tumor-targeting magnetic nanoparticles (MNP) under a non-invasive magnetic field. However, one of the remaining challenges is how to achieve therapeutic levels of heat (without causing damages to regular tissues) in tumors that cannot be effectively treated with anti-tumor drug delivery. RESULTS: In this work, we report a facile method to fabricate magnetic nanorods for hyperthermia by one-step wet chemistry synthesis using 3-Aminopropyltrimethoxysilane (APTMS) as the shape-controlling agent and ferric and ferrous ions as precursors. By adjusting the concentration of APTMS, hydrothermal reaction time, ratios of ferric to ferrous ions, magnetic nanorods with aspect ratios ranging from 4.4 to 7.6 have been produced. At the clinically recommended field strength of 300 Oe (or less) and the frequency of 184 kHz, the specific absorption rate (SAR) of these nanorods is approximately 50 % higher than that of commercial Bionized NanoFerrite particles. CONCLUSIONS: This increase in SAR, especially at low field strengths, is crucial for treating deep tumors, such as pancreatic and rectal cancers, by avoiding the generation of harmful eddy current heating in normal tissues.
Authors: Alexandra Bolocan; Dan Eduard Mihaiescu; Ecaterina Andronescu; Georgeta Voicu; Alexandru Mihai Grumezescu; Anton Ficai; Bogdan Ştefan Vasile; Coralia Bleotu; Mariana Carmen Chifiriuc; Corina Silvia Pop Journal: Rom J Morphol Embryol Date: 2015 Impact factor: 1.033
Authors: Beatriz Sanz; M Pilar Calatayud; Teobaldo E Torres; Mónica L Fanarraga; M Ricardo Ibarra; Gerardo F Goya Journal: Biomaterials Date: 2016-11-09 Impact factor: 12.479
Authors: Costas G Hadjipanayis; Michael J Bonder; Srinivasan Balakrishnan; Xiaoxia Wang; Hui Mao; George C Hadjipanayis Journal: Small Date: 2008-11 Impact factor: 13.281
Authors: Susanne Kossatz; Julia Grandke; Pierre Couleaud; Alfonso Latorre; Antonio Aires; Kieran Crosbie-Staunton; Robert Ludwig; Heidi Dähring; Volker Ettelt; Ana Lazaro-Carrillo; Macarena Calero; Maha Sader; José Courty; Yuri Volkov; Adriele Prina-Mello; Angeles Villanueva; Álvaro Somoza; Aitziber L Cortajarena; Rodolfo Miranda; Ingrid Hilger Journal: Breast Cancer Res Date: 2015-05-13 Impact factor: 6.466